The University of Chicago ( Site 0264) — Chicago, Illinois

The University of Chicago ( Site 0264) is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Chicago ( Site 0264) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Hormone-Sensitive Prostate Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Chicago ( Site 0264)?

The University of Chicago ( Site 0264) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Chicago ( Site 0264) conducted?

The University of Chicago ( Site 0264) has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic Hormone-Sensitive Prostate Cancer.

Is The University of Chicago ( Site 0264) accredited by Crixeo Health?

The University of Chicago ( Site 0264) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Chicago ( Site 0264)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.